Page last updated: 2024-10-21

1-anilino-8-naphthalenesulfonate and Berardinelli Syndrome

1-anilino-8-naphthalenesulfonate has been researched along with Berardinelli Syndrome in 2 studies

1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Fukaishi, T1
Minami, I1
Masuda, S1
Miyachi, Y1
Tsujimoto, K1
Izumiyama, H1
Hashimoto, K1
Yoshida, M1
Takahashi, S1
Kashimada, K1
Morio, T1
Kosaki, K1
Maezawa, Y1
Yokote, K1
Yoshimoto, T1
Yamada, T1
Zhou, H1
Lei, X1
Yan, Y1
Lydic, T1
Li, J1
Weintraub, NL1
Su, H1
Chen, W1

Other Studies

2 other studies available for 1-anilino-8-naphthalenesulfonate and Berardinelli Syndrome

ArticleYear
A case of generalized lipodystrophy-associated progeroid syndrome treated by leptin replacement with short and long-term monitoring of the metabolic and endocrine profiles.
    Endocrine journal, 2020, Feb-28, Volume: 67, Issue:2

    Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Blood Glucose; Diabetes Mellitus; Dyslipid

2020
Targeting ATGL to rescue BSCL2 lipodystrophy and its associated cardiomyopathy.
    JCI insight, 2019, 06-11, Volume: 5

    Topics: Adipocytes; Adipose Tissue; Animals; Cardiomyopathies; Cell Differentiation; Disease Models, Animal;

2019